Ledger.Open graph →
SEC Form D · filed March 2, 2017

Arrakis Therapeutics, Inc

Offering
$41.2M
Sold
$13.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Michael Gilman · CAMBRIDGE, MAExec · DirectorMichael Gilman · Belmont, MAExec · DirectorRussell C. Petter · Cambridge, MAExecAlan E. Walts · Cambridge, MADirectorRaj Parekh · Santa Monica, CADirectorDavid E. Neafus · Cambridge, MAExecCarolyn E. Green · Cambridge, MADirectorRussell C. Petter · Cambridge, MAExecAlan E. Walts · Cambridge, MADirectorColleen E. Cuffaro · Cambridge, MADirectorRaj Parekh · Waltham, MADirectorCarolyn E. Green · Cambridge, MADirectorColleen E. Cuffaro · Cambridge, MADirectorDavid E. Neafus · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗